Monthly Archives: July 2020

//July

Contact centre update

Our phone lines are closed this afternoon (14 July) and will re-open at 9.30am tomorrow (15 July). Our contact centre can be reached during this time via email at info@pharmacyregulation.org. You can also visit our dedicated COVID-19 webpage detailing ...

By |July 14th, 2020|Lexpos News|Comments Off on Contact centre update

Contact centre update

Our phone lines are closed this afternoon (14 July) and will re-open at 9.30am tomorrow (15 July). Our contact centre can be reached during this time via email at info@pharmacyregulation.org. You can also visit our dedicated COVID-19 webpage detailing ...

By |July 14th, 2020|Lexpos News|Comments Off on Contact centre update

Contact centre update

Our phone lines are closed this afternoon (09 July) and will re-open at 9.30am tomorrow (10 July). Our contact centre can be reached during this time via email at info@pharmacyregulation.org. You can also visit our dedicated COVID-19 webpage detailing our latest updates and our COVID-19 Q&A.

By |July 9th, 2020|Lexpos News|Comments Off on Contact centre update

Contact centre update

Our phone lines are closed this afternoon (09 July) and will re-open at 9.30am tomorrow (10 July). Our contact centre can be reached during this time via email at info@pharmacyregulation.org. You can also visit our dedicated COVID-19 webpage detailing our latest updates and our COVID-19 Q&A.

By |July 9th, 2020|Lexpos News|Comments Off on Contact centre update

Response to the Independent Medicines and Medical Devices Safety Review

Responding to the publication of the report from the Independent Medicines and Medical Devices Safety Review, Duncan Rudkin, Chief Executive of the General Pharmaceutical Council, said:

“This important report shines a spotlight on how medicines and medical devices can harm as well as help. We will carefully review the report and its strategic recommendations and look at what actions we can take in response.

By |July 8th, 2020|Lexpos News|Comments Off on Response to the Independent Medicines and Medical Devices Safety Review